Takeda Pharmaceutical Company Limited vs Aflac Incorporated
Vergleich der Marktkapitalisierung im Zeitverlauf
Takeda Pharmaceutical Company Limited
$59.0B
Rang #245
Aflac Incorporated
$60.7B
Rang #240
Marktkapitalisierung im Zeitverlauf
Wichtige Momente
- Aflac Incorporated überholte Takeda Pharmaceutical Company Limited bis 2023
Vergleich Jahr für Jahr
| Jahr | Takeda Pharmaceutical Company Limited | Aflac Incorporated | Spitzenreiter |
|---|---|---|---|
| 2026 | $59.0B | $60.7B | Aflac Incorporated |
| 2025 | $50.3B | $55.5B | Aflac Incorporated |
| 2024 | $41.6B | $51.0B | Aflac Incorporated |
| 2023 | $38.6B | $39.8B | Aflac Incorporated |
| 2022 | $37.6B | $33.9B | Takeda Pharmaceutical Company Limited |
| 2021 | $27.3B | $26.8B | Takeda Pharmaceutical Company Limited |
| 2020 | $31.2B | $19.9B | Takeda Pharmaceutical Company Limited |
| 2019 | $34.2B | $23.1B | Takeda Pharmaceutical Company Limited |
| 2018 | $28.0B | $19.5B | Takeda Pharmaceutical Company Limited |
| 2017 | $46.8B | $18.3B | Takeda Pharmaceutical Company Limited |
| 2016 | $34.2B | $14.2B | Takeda Pharmaceutical Company Limited |
| 2015 | $41.4B | $11.9B | Takeda Pharmaceutical Company Limited |
| 2014 | $33.1B | $11.9B | Takeda Pharmaceutical Company Limited |
| 2013 | $30.8B | $12.7B | Takeda Pharmaceutical Company Limited |
| 2012 | $23.7B | $9.8B | Takeda Pharmaceutical Company Limited |
| 2011 | $19.8B | $7.8B | Takeda Pharmaceutical Company Limited |
| 2010 | $22.3B | $9.9B | Takeda Pharmaceutical Company Limited |
| 2009 | $20.5B | $7.9B | Takeda Pharmaceutical Company Limited |
| 2008 | $23.7B | $7.6B | Takeda Pharmaceutical Company Limited |
| 2007 | $32.5B | $10.2B | Takeda Pharmaceutical Company Limited |
| 2006 | $39.6B | $7.3B | Takeda Pharmaceutical Company Limited |
| 2005 | $30.4B | $7.3B | Takeda Pharmaceutical Company Limited |
| 2004 | $24.2B | $6.2B | Takeda Pharmaceutical Company Limited |
| 2003 | $19.6B | $5.6B | Takeda Pharmaceutical Company Limited |
| 2002 | $22.5B | $4.6B | Takeda Pharmaceutical Company Limited |
| 2001 | $26.6B | $3.7B | Takeda Pharmaceutical Company Limited |
| 2000 | $30.0B | $5.5B | Takeda Pharmaceutical Company Limited |